首页> 美国卫生研究院文献>Bentham Open Access >Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels
【2h】

Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels

机译:对二酰基甘油敏感的TRPC3 / 6/7通道的药理调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Members of the classic type of transient receptor potential channels (TRPC) represent important molecules involved in hormonal signal transduction. TRPC3/6/7 channels are of particular interest as they are components of phospholipase C driven signalling pathways. Upon receptor-activation, G-protein-mediated stimulation of phospholipase C results in breakdown of phosphatidylinositides leading to increased intracellular diacylglycerol and inositol-trisphosphate levels. Diacylglycerol activates protein kinase C, but more interestingly diacylglycerol directly activates TRPC2/3/6/7 channels. Molecular cloning, expression and characterization of TRP channels enabled reassignment of traditional inhibitors of receptor-dependent calcium entry such as SKF-96365 and 2-APB as blockers of TRPC3/6/7 and several members of non-classic TRP channels. Furthermore, several enzyme inhibitors have also been identified as TRP channel blockers, such as ACA, a phospholipase A2 inhibitor, and W-7, a calmodulin antagonist. Finally, the naturally occurring secondary plant compound hyperforin has been identified as TRPC6-selective drug, providing an exciting proof of concept that it is possible to generate TRPC-selective channel modulators. The description of Pyr3 as the first TRPC3-selective inhibitor shows that not only nature but also man is able to generate TRP-selective modulators. The review sheds lights on the current knowledge and historical development of pharmacological modulators of TRPC3/6/7. Our analysis indicates that Pyr3 and hyperforin provide promising core structures for the development of new, selective and more potent modulators of TRPC3/6/7 activity.
机译:经典类型的瞬时受体电位通道(TRPC)的成员代表参与激素信号转导的重要分子。 TRPC3 / 6/7通道特别受关注,因为它们是磷脂酶C驱动的信号通路的组成部分。受体激活后,G蛋白介导的磷脂酶C刺激导致磷脂酰肌醇分解,导致细胞内二酰基甘油和肌醇三磷酸水平升高。二酰基甘油激活蛋白激酶C,但更有趣的是,二酰基甘油直接激活TRPC2 / 3/6/7通道。 TRP通道的分子克隆,表达和表征能够重新分配传统的受体依赖性钙进入抑制剂,例如SKF-96365和2-APB,作为TRPC3 / 6/7和非经典TRP通道的阻滞剂。此外,还已经确定了几种酶抑制剂作为TRP通道阻滞剂,例如ACA(磷脂酶A2抑制剂)和W-7(钙调蛋白拮抗剂)。最后,天然存在的植物辅助化合物Hyperforin被鉴定为TRPC6选择性药物,提供了令人兴奋的概念证明,即可以产生TRPC选择性通道调节剂。对Pyr3作为第一个TRPC3选择性抑制剂的描述表明,不仅自然界,而且人类也能够产生TRP选择性调节剂。审查阐明了TRPC3 / 6/7的药物调节剂的当前知识和历史发展。我们的分析表明Pyr3和hyperforin为开发新型,选择性和更有效的TRPC3 / 6/7活性调节剂提供了有希望的核心结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号